Fungal necrotizing external otitis: diagnosis, management and outcomes of 15 cases

• Published in: The Pan African medical journal Vol. 42
• Main Authors: El Korbi, Amel, Haouas, Jihene, Kolsi, Naourez, Bouatay, Rachida, Ferjaoui, Mehdi, Toumi, Adnene, Harrathi, Khaled, Koubaa, Jamel
• Format: Journal Article
• Language: English
• Published: The African Field Epidemiology Network 24-08-2022
• Subjects: Case Series
• ISSN: 1937-8688; 1937-8688
• DOI: 10.11604/pamj.2022.42.306.27168

Fungal necrotizing external otitis (NEO) is a rare disease. It is an aggressive and potentially fatal infection. The most commonly reported pathogen is Candida. We aim through this study to share our experience in the management of fungal necrotizing external otitis and discuss its diagnosis tools, anti-fungal treatment choice, and outcomes. We included fifteen patients with diagnosis criteria of fungal NEO; clinical features of NEO with positive culture swabs and/or positive serologic test to a fungal pathogen. The mean age was of 70 years with a prevalence of males. The main symptoms were otalgia (n=15) and otorrhea (n=7). Facial palsy was observed in four cases. Fungal pathogens were Candida(n=10) and Aspergillus (n=5). Complications were observed in eight cases: extension to the temporo-mandibular (n=4), abscess in the retropharyngeal space (n=2), abscess in the parapharyngeal space (n=1) and thrombophlebitis of the internal jugular vein (n=1). Six patients were treated with fluconazole, eight with voriconazole, and one patient with itraconazole. After a mean duration of 52 days of antifungal therapy, fourteen patients have been cured with normalization of the ear symptoms, biological, and imaging features. One patient died of septic shock. No recurrence of the disease was observed after a follow-up of 12 months in all cases.